Thanks for visiting Research Information.

You're trying to access an editorial feature that is only available to logged in, registered users of Research Information. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

Sage buys Libertas Academica portfolio

Share this on social media:

Sage Publishing has announced the purchase of the full portfolio of journals from the open access publisher, Libertas Academica.

Founded in 2004, Libertas Academica is an independent publisher specialising in clinical medicine, biological sciences and chemistry. The publishing portfolio covers topics such as cardiology, neurology, biochemistry, genetics, and analytical chemistry. Sage will publish the full journal portfolio of 83 titles.

David Ross, Sage publishing’s executive director of open access, commented: 'Sage has always been committed to driving forwards open business models in the scholarly communications market, and this acquisition clearly demonstrates our long term commitment to OA publishing.

'Libertas Academica’s solid, high quality journal program perfectly complements Sage’s existing OA program, and we are delighted to be able to welcome such a broad spectrum of journals.'
 
Libertas Academica's CEO Tom Hill added: 'Since Libertas Academica was established over a decade ago, our publishing goal was to support high quality open access global publishing. Sage is one of those rare companies who has the global reach of a large business, with the mindset, culture and adaptability of an innovative supportive company, working directly with the scholarly community.

'We are delighted that Sage is taking over the publication portfolio and know with confidence that Sage is the right publisher to take forwards the development of these journals. We look forward to seeing the journals prosper in their new home.'